Skip to Content

Clinical Trial Detail

GOG 0213

Patient Information

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (Or Gemcitabine)Alone or in Combination with Bevacizumab (NSC #704865, IND #113912) followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer

Study Number
GOG 0213

Clinical Trial Categories

  • Ovarian Cancer

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725

Directions

Large Conference Room: Please enter the building through the door to the right of the main entrance…this door is a direct entrance to our meeting room. The Valet service is operating at our main entrance for our patients.

Also in this Section